These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 3016942

  • 21. Relation between the inhibition of aggregation and the concentration of cAMP in human and rat platelets.
    Michel H, Caen JP, Born GV, Miller R, D'Auriac GA, Meyer P.
    Br J Haematol; 1976 May; 33(1):27-38. PubMed ID: 178342
    [Abstract] [Full Text] [Related]

  • 22. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
    Lam SC, Guccione MA, Packham MA, Mustard JF.
    Thromb Haemost; 1982 Apr 30; 47(2):90-5. PubMed ID: 6285543
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of cyclic AMP phosphodiesterase activity of human blood platelet membrane by ADP.
    Kahn NN, Sinha AK.
    Biochim Biophys Acta; 1989 Aug 21; 984(1):113-8. PubMed ID: 2548620
    [Abstract] [Full Text] [Related]

  • 24. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.
    Mills DC, Smith JB.
    Biochem J; 1971 Jan 21; 121(2):185-96. PubMed ID: 4330088
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Nucleoside transport inhibitors enhance the infarct size-limiting effect of ischemic preconditioning.
    Itoya M, Miura T, Sakamoto J, Urabe K, Iimura O.
    J Cardiovasc Pharmacol; 1994 Nov 21; 24(5):846-52. PubMed ID: 7532764
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Mechanism of anti-platelet aggregating action of dilazep.
    Takenaga M, Kitagawa H, Hirai A, Tamura Y, Yoshida S.
    J Pharmacobiodyn; 1985 Feb 21; 8(2):77-83. PubMed ID: 3925115
    [Abstract] [Full Text] [Related]

  • 30. Interplay between milrinone and adenosine in the inhibition of human platelet response.
    Anfossi G, Massucco P, Piretto V, Mularoni E, Cavalot F, Mattiello L, Trovati M.
    Gen Pharmacol; 1996 Oct 21; 27(7):1149-54. PubMed ID: 8981060
    [Abstract] [Full Text] [Related]

  • 31. Effects of dilazep on human platelets and rat vascular tissue: in vitro studies on platelet aggregation, and arachidonic acid oxidation.
    Colli S, Maderna P, Morazzoni G, Speroni C, Tremoli E.
    Pharmacol Res Commun; 1983 Jun 21; 15(6):593-602. PubMed ID: 6412253
    [Abstract] [Full Text] [Related]

  • 32. Functional and biochemical evidence of a specific adenosine A2/Ra receptor on human platelets.
    Quattrin S, Genovese A, Cirillo R, Formisano S, Marone G.
    Ric Clin Lab; 1988 Jun 21; 18(2-3):105-18. PubMed ID: 2850603
    [Abstract] [Full Text] [Related]

  • 33. Potentiation by dilazep on the negative inotropic effect of adenosine on guinea-pig atria.
    Fujita S, Ishida Y, Izumi K, Moritoki H, Ohara M, Takei M.
    Br J Pharmacol; 1980 Feb 21; 68(2):343-9. PubMed ID: 7357212
    [Abstract] [Full Text] [Related]

  • 34. Y-590 (a new pyridazinone derivative), a potent anti-thrombotic agent--II. Inhibition of platelet phosphodiesterase.
    Mikashima H, Nakao T, Goto K, Ochi H, Yasuda H, Tsumagari T.
    Thromb Res; 1984 Sep 01; 35(5):589-94. PubMed ID: 6091293
    [Abstract] [Full Text] [Related]

  • 35. Human platelet aggregation tests in vitro. Effects of dilazep.
    Ponari O, Manotti C.
    Arzneimittelforschung; 1981 Sep 01; 31(1):97-101. PubMed ID: 7194099
    [Abstract] [Full Text] [Related]

  • 36. Mechanism of action of dipyridamole.
    Harker LA, Kadatz RA.
    Thromb Res Suppl; 1983 Sep 01; 4():39-46. PubMed ID: 6356465
    [Abstract] [Full Text] [Related]

  • 37. Effect of dipyridamole on spontaneous platelet aggregation in whole blood decreases with the time after venepuncture: evidence for the role of ADP.
    Saniabadi AR, Lowe GD, Barbenel JC, Forbes CD.
    Thromb Haemost; 1987 Aug 04; 58(2):744-8. PubMed ID: 3672426
    [Abstract] [Full Text] [Related]

  • 38. Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets.
    Cooper JA, Hill SJ, Alexander SP, Rubin PC, Horn EH.
    Br J Clin Pharmacol; 1995 Jul 04; 40(1):43-50. PubMed ID: 8527267
    [Abstract] [Full Text] [Related]

  • 39. Dipyridamole inhibits platelet aggregation in whole blood.
    Gresele P, Zoja C, Deckmyn H, Arnout J, Vermylen J, Verstraete M.
    Thromb Haemost; 1983 Dec 30; 50(4):852-6. PubMed ID: 6665766
    [Abstract] [Full Text] [Related]

  • 40. Enhancement of the immune response to sheep erythrocytes in mice by phosphodiesterase-inhibiting dipyridamole derivatives.
    Lichtner R, Wedderburn N.
    J Immunopharmacol; 1984 Dec 30; 6(1-2):43-55. PubMed ID: 6088639
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.